Investigating idiopathic inflammatory myopathy; initial cross speciality experience with use of the extended myositis antibody panel
The discovery of unique autoantibodies has informed and altered our approach to the diagnosis and management of the inflammatory myopathies. This study reports the initial clinical experience of use of the Extended Myositis Antibody (EMA) panel in the largest university teaching hospital in Ireland....
Main Authors: | Antoinette O'Connor, Jennifer Mulhall, Sinead M.J. Harney, John G. Ryan, Grainne Murphy, Michael T. Henry, Peter Annis, Vincent Tormey, Aisling Ryan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-05-01
|
Series: | Clinics and Practice |
Subjects: | |
Online Access: | https://www.clinicsandpractice.org/index.php/cp/article/view/922 |
Similar Items
-
Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis
by: Marcela Gran Pina Cruellas, et al.
Published: (2013-07-01) -
Role of myositis-specific autoantibodies in personalized therapy
by: Anand N Malaviya, et al.
Published: (2018-01-01) -
Clinical usefulness of autoantibodies in idiopathic inflammatory myositis
by: Ignacio eGarcia-De La Torre
Published: (2015-06-01) -
The promise, perceptions, and pitfalls of immunoassays for autoantibody testing in myositis
by: Sarah L. Tansley, et al.
Published: (2020-05-01) -
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
by: Hanbo Yang, et al.
Published: (2017-11-01)